{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-112136","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.232314+00:00","generated_at":"2026-05-16T18:50:16.234126+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Shareholders approve option repricing to $1.50; CTAD presentations set for Dec 1-4","bullets":["Special meeting approves repricing of up to 5,511,000 outstanding stock options for employees, execs, and directors to $1.50 per share.","Voting results: 7,144,433 for, 2,926,973 against, 121,836 abstentions.","Repricing effective Nov 18; exercise price set at closing price of $1.50 on Nasdaq that day.","Two presentations at CTAD conference Dec 1-4: Phase 2 MINDFuL trial results for XPro1595 in early Alzheimer’s, and EMACC validation.","Phase 2 trial data on selective soluble TNF neutralizer XPro1595 to be presented as a poster."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-112136","json":"https://secwatch.observer/filing/0001213900-25-112136.json","markdown":"https://secwatch.observer/filing/0001213900-25-112136.md","text":"https://secwatch.observer/filing/0001213900-25-112136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025112136/0001213900-25-112136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025112136/ea0266048-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:50:16.234126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}